Results
Solara Q2 Consolidated Net Profit Rises to ₹28.46 Crores
Solara Active Pharma Sciences reported unaudited consolidated financial results for Q2 and H1 FY27, approved by the board on October 16, 2026.
Consolidated revenue from operations grew to ₹417.34 cror
